Association for Clinical & Translational Science

Nonprofit profile at a glance

EIN
264245965
IRS 990 coverage
2010–2025
Forms available
Form 990 2025, Form 990-T 2025
Location
Washington, DC, USA
Phone
3126735523
Rating
72
Verdict
SUPPORTED
Rating confidence
Moderate
Sector
Social Science N.E.C.

Official website

Reported finances

Revenue
$1,533,366
Expenses
$1,392,439
Assets
$1,893,352
Liabilities
$412,460

Source: IRS Form 990. Selected filing: tax year 2025. Amounts in USD.

Leadership & pay

16 people listed

Executive titles in this filing

  • LINDA COTTLER (PAST PRESIDENT)
  • ALLAN BRASIER (PRESIDENT)
  • KIM STELMASZAK (EXECUTIVE DIRECTOR)

People named in this filing

  • LINDA COTTLER (PAST PRESIDENT)
  • ALLAN BRASIER (PRESIDENT)
  • JOYCE BALLS-BERRY (SECRETARY)

Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.

Source: IRS Form 990. Selected filing: tax year 2025. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

Advance research and education in clinical and translational science to improve human health.

What it reported doing in 2025

Conference - the association conducts an annual meeting to bring together all of the disciplines involved in clinical and translational research, for the shared benefits of networking and education with the goal to: a) inspire the participants by identifying the great successes of clinical and translational research and describing how they have improved the lives of so many people; b) provide participants with the newest and most valuable information in clinical and translational science; c) provide trainees and all meeting participants an opportunity to present their research to a supportive group of their peers, educators, and senior investigators; d) communicate novel methods, best practices, and resources for clinical translation; e) provide exciting and dynamic career development programs for trainees and their mentors; and f) provide educators a venue to present best practices in clinical and translational research career development.

Operating model

Revenue model
Earned-program. 97% of the money available for current operations came from fees and other program revenue.
Distribution model
Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

SUPPORTED - The filed numbers largely add up and most voting board members are independent. A relatively small share of available resources goes toward mission work and a relatively small share of total spending goes to programs.

Rating breakdown

  • Financial Efficiency: 46
  • Transparency & Controls: 90
  • Accountability: 94
  • Sustainability: 53
  • Growth: 100

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 50%; rating input score 50
  • Program expense ratio: 56.4%; rating input score 56
  • Fundraising efficiency: Limited

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
  • Pay-setting controls: Limited
  • Foreign activity oversight: Limited
  • Grant itemization coverage: Limited
  • Major donor itemization: Limited
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 100%; rating input score 100; 64th percentile among comparable filings
  • Governance controls: 6 of 7 controls in place; rating input score 86
    • Conflict-of-interest policy: Pass
    • Whistleblower policy: Pass
    • Document-retention policy: Fail
    • CEO compensation review process: NotApplicable
    • Other executive compensation review process: NotApplicable
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Pass
    • Independent financial-statement audit: Pass

Sustainability

  • Operating margin: 9.2%; rating input score 54; 54th percentile among comparable filings
  • Total-asset coverage ratio: 1.36; rating input score 52; 52nd percentile among comparable filings
  • Liabilities to assets ratio: 0.22; rating input score 24; 24th percentile among comparable filings
  • Officer compensation ratio: 0%; rating input score 78; 78th percentile among comparable filings

Growth

  • Program expense growth: 6.2% per year; rating input score 100; 42nd percentile among comparable filings
  • Revenue growth: 4.2% per year; rating input score 100; 33rd percentile among comparable filings
  • Asset growth: 8.6% per year; rating input score 100; 50th percentile among comparable filings

Details

  • Where the money goes: 50% of revenue deployed · 56.4% of spending went to programs
  • Governance: 15 of 15 board members independent · 6 of 7 filing controls reported
  • Programs: 2 filed program accomplishments · $786K in reported program spending
  • Leadership: top reported pay $0 · 16 people listed
  • Highest-paid contractors: 1 contractor listed · $818K reported
  • Consistency: 24 of 24 current checks pass
  • Schedules: 4 filed schedules
  • Filing history: 13 filing years from 2010 to 2025
  • Contacts: How to reach this organization
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • Review — Financial Efficiency: Mission deployment rate scored 50/100.
  • Review — Financial Efficiency: Program expense ratio scored 56/100.
  • Review — Accountability: Governance controls: Document-retention policy not reported.
  • Review — Sustainability: Operating margin scored 54/100.
  • Review — Sustainability: Total-asset coverage ratio scored 52/100.
  • High — Sustainability: Liabilities to assets ratio scored 24/100.